EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Vaccinia virus growth factor induces divergent signaling programs and biological outcomes from cellular epidermal growth factor

Anil Pant, Lara Dsouza, Zhilong Yang iD

PLOS Pathogens · 2026

DOI: 10.1371/journal.ppat.1014725 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Pathogens, 2026. Verfasst von Anil Pant und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Veterinary Pathobiology, College of Veterinary Medicine & Biomedical Sciences, Texas A&M University, College Station, Texas, United Sta…. Hauptthemen laut MEDLINE: Vaccinia virus, Signal Transduction, Epidermal Growth Factor, Viral Proteins. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, Division of Intramural Research, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epidermal growth factor receptor (EGFR) signaling is a major pathway that controls cellular growth, survival, proliferation, and differentiation. Viruses often hijack this pathway to create a favorable environment to support their replication. Vaccinia virus (the prototype member of poxviridae ) encodes its own viral growth factor (VGF). VGF is a secreted viral polypeptide with sequence and structural homology to the cellular EGF, which binds to and activates EGFR signaling. Studies from our lab and others have shown that VGF promotes metabolic reprogramming, cell motility, virulence, and spread during VACV infection. However, it remains unclear whether VGF fully mimics EGF signaling or selectively rewires downstream pathways to meet the specific demands of viral replication. To address this question, we used quantitative global phosphoproteomics to systematically compare signaling programs induced by EGF and VGF in primary human foreskin fibroblasts. By analyzing global phosphorylation patterns, kinase activity inference, and motif enrichment, we found that although both peptides engage the same EGFR receptor, EGF and VGF induce distinct downstream phosphorylation and bias downstream kinase activities. Transcriptomic analysis provided a complementary view of the cellular responses to the ligand treatment. Moreover, we found that VGF is more effective at promoting VACV plaque formation than EGF, thereby providing functional support to the VGF-biased EGFR signaling nodes important for viral spread. These findings highlight differences in how viral and cellular growth factors activate EGFR signaling and position poxviral growth factors as powerful tools for examining the fundamental principles of cellular signaling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vaccinia virusSignal TransductionEpidermal Growth FactorViral ProteinsVacciniaHumansErbB ReceptorsFibroblastsPhosphorylationVirus ReplicationCells, CulturedIntercellular Signaling Peptides and Proteins

Substanzen

Epidermal Growth FactorErbB ReceptorsViral Proteinsvaccinia growth factorIntercellular Signaling Peptides and Proteins

Autor:innen und Institutionen

  • Department of Veterinary Pathobiology, College of Veterinary Medicine & Biomedical Sciences, Texas A&M University, College Station, Texas, United States of America.

ORCID-Profile: Zhilong Yang

Förderung

  • NIAID NIH HHS
  • Division of Intramural Research, National Institute of Allergy and Infectious Diseases

Zitieren

APA

Pant, A., Dsouza, L., & Yang, Z. (2026). Vaccinia virus growth factor induces divergent signaling programs and biological outcomes from cellular epidermal growth factor. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1014725

Vancouver

Pant A, Dsouza L, Yang Z. Vaccinia virus growth factor induces divergent signaling programs and biological outcomes from cellular epidermal growth factor. PLOS Pathogens. 2026. doi:10.1371/journal.ppat.1014725

BibTeX
@article{Pant2026,
  author = {Pant, Anil and Dsouza, Lara and Yang, Zhilong},
  title = {Vaccinia virus growth factor induces divergent signaling programs and biological outcomes from cellular epidermal growth factor},
  journal = {PLOS Pathogens},
  year = {2026},
  doi = {10.1371/journal.ppat.1014725}
}
Kostenlos starten →